T2769

DEVICE6 trials

Sponsors

Laboratoires Thea

Conditions

Dry EyeDry Eye Disease (DED)Dry Eye Syndrome

Unknown Phase

Efficacy, Safety of T2769 in Dry Eye Disease

CompletedNCT03830359

Laboratoires TheaDry Eye Syndrome

Start: 2018-09-01End: 2019-02-18Updated: 2022-03-16

Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.

CompletedNCT05931861

Laboratoires TheaDry Eye

Start: 2023-08-15End: 2023-12-04Updated: 2025-01-31

Performance and Safety of T2769 in DED

CompletedNCT05965778

Laboratoires TheaDry Eye

Start: 2023-10-02End: 2024-08-15Updated: 2026-01-23

Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

CompletedNCT06375499

Laboratoires TheaDry Eye Syndrome

Start: 2024-09-17End: 2025-01-06Updated: 2026-01-02

New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye

CompletedNCT06903741

Laboratoires TheaDry Eye Disease (DED)

Start: 2025-10-21End: 2026-07-26Updated: 2026-08-17

Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease

CompletedNCT07007702

Laboratoires TheaDry Eye Disease (DED)

Start: 2025-01-27End: 2025-06-30Updated: 2025-09-25